Notable examples include Glycogen synthase kinase 3β (GSK3β), as a high throughput screen of 99 anti-cancer compounds determined that GSK3β inhibition cooperated with PARP inhibitors in colon cancer, suppressing HR and increasing both replication stress and DNA double-strand breaks [120]. This evidence concerns the gene GSK3B and malignant colon neoplasm.